Avalo Therapeutics Inc (AVTX)

NASDAQ · Biotechnology

11.84
-0.17 (-1.42%)
Updated Oct 15, 1:25 PM ET
AI Rating
Sell
Overall Score
36
Trend
30
Momentum
28
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 30, 2025 260 sessions Oct 12, 2026

AI Analysis

Avalo Therapeutics Inc is trading at $11.84, down 1.42% on the session. The 50 day average sits at $17.52 and the 200 day at $16.58, which puts the stock in a uptrend. RSI is at 27.3, which reads as oversold, and MACD is bearish crossover. Volume is below average.

The nearest support is around $12.77 with resistance near $15.99, so that band frames the current range. Average daily movement is roughly $0.88, or about 7.4% of the share price, which is what any stop placement has to allow for. The overall health score of 36 out of 100 combines a trend score of 30, momentum of 28 and a risk score of 58.

Technical indicators

RSI (14)
27.3
oversold
MACD
-1.173
bearish crossover
SMA 20
15.16
SMA 50
17.52
SMA 200
16.58
uptrend
ATR (14)
0.88
avg daily range
Support
12.77
Resistance
15.99
Volume vs 20d
0.45x
below average
Volatility
47.0%
annualised
1 month
-17.87%
3 months
-28.12%

AI trade signals on AVTX

All signals
Date Setup Entry Target Stop R:R Status
Aug 20 Breakout ••.•• ••.•• ••.•• 1.61:1 Expired

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.